𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chromosomal breakage in Crohn's disease: Anticlastogenic effect of D-penicillamine and L-cysteine

✍ Scribed by I. Emerit; J. Emerit; A. Levy; M. Keck


Publisher
Springer
Year
1979
Tongue
English
Weight
363 KB
Volume
50
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

✦ Synopsis


The incidence of chromosome breakage was found to be elevated in 42 patients with Crohn's disease. This phenomenon was much more striking in cultures set up with TCM 199 than in cultures set up with RPMI 1629 rich in L-cysteine. The drug D-penicillamine, a close analog of L-cysteine, gave an apparent therapeutic response in several patients and reduced the chromosome breakage frequency in the lymphocytes of these patients in vitro and in vivo.


πŸ“œ SIMILAR VOLUMES


Comparison of the effects of 1,25 dihydr
✍ PΓ‘l Miheller; GyΓΆrgyi MΕ±zes; IstvΓ‘n Hritz; GΓ‘bor Lakatos; IstvΓ‘n Pregun; PΓ©ter L πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

Background: Vitamin D is essential for osteopenia therapy in Crohn's disease (CD). The active form of vitamin-D (aVD) is the 1,25(OH)2D. There are no data available whether aVD or plain vitamin-D (pVD) has any advantage in managing osteoporosis in CD or has any effect on the activity of the disease

Characterization of intestinal gene expr
✍ Colin L. Noble; Alexander R. Abbas; Charles W. Lees; Jennine Cornelius; Karen To πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 484 KB

Background: Genome-wide microarray expression analysis creates a comprehensive picture of gene expression at the cellular level. The aim of this study was to investigate differential intestinal gene expression in patients with Crohn's disease (CD) and controls with subanalysis of confirmed CD suscep

Effect of medication on EMG patterns in
✍ Julie A. Robichaud; Kerstin D. Pfann; Cynthia L. Comella; Daniel M. Corcos πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 184 KB πŸ‘ 1 views

## Abstract Individuals with Parkinson's disease show dramatic improvements in their ability to move when medicated. However, the neural cause of this improvement is unclear. One hypothesis is that neural activation patterns, as measured by surface electromyography (EMG), are normalized by medicati